Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
18.55
-0.66 (-3.44%)
Aug 11, 2025, 11:12 AM - Market open
Paramount Global Revenue
Schrödinger had revenue of $54.76M in the quarter ending June 30, 2025, with 15.69% growth. This brings the company's revenue in the last twelve months to $237.92M, up 18.59% year-over-year. In the year 2024, Schrödinger had annual revenue of $207.54M, down -4.21%.
Revenue (ttm)
$237.92M
Revenue Growth
+18.59%
P/S Ratio
5.90
Revenue / Employee
$267,022
Employees
891
Market Cap
1.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 207.54M | -9.13M | -4.21% |
Dec 31, 2023 | 216.67M | 35.71M | 19.73% |
Dec 31, 2022 | 180.96M | 43.02M | 31.19% |
Dec 31, 2021 | 137.93M | 29.84M | 27.60% |
Dec 31, 2020 | 108.10M | 22.55M | 26.36% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
SDGR News
- 4 days ago - Schrödinger, Inc. (SDGR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Schrödinger Reports Second Quarter 2025 Financial Results - Business Wire
- 17 days ago - Schrödinger to Announce Second Quarter 2025 Financial Results on August 6 - Business Wire
- 24 days ago - Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration - GlobeNewsWire
- 24 days ago - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 25 days ago - Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target - Business Wire
- 6 weeks ago - Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia - Business Wire
- 2 months ago - Schrödinger: Assessing The Signal And The Noise In The Phase 1 Results - Seeking Alpha